News
Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA
By Stephanie Brown HealthDay ReporterTUESDAY, June 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...
The federal government should be investing and working to expand the nation’s scientific and public health arsenal, not ...
KEY TAKEAWAYS U.S. equities were mixed at midday after China accused the U.S. of violating a trade deal the two countries ...
Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback